9:22 AM
Leo Group India
| ||
| Valeant Pharmaceuticals buying Visudyne treatment for blindness from QLT CanadianBusiness.com Valeant, which has acquired numerous products and companies since it absorbed the former Biovail pharmaceutical business, said Monday that it sees Visudyne as a valuable addition to the company's ophthalmology business. "Not only will we be able to ... See all stories on this topic » | ||
| Moody's upgrades pharmaceutical industry to stable Businessweek WASHINGTON (AP) — Moody's Investors Service upgraded its outlook for the global pharmaceutical industry on Monday, saying the multiyear wave of drug patent expirations that have squeezed profits should subside next year. The ratings service upgraded ... See all stories on this topic » | ||
| Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer Sacramento Bee BRIDGEWATER, N.J., Sept. 24, 2012 -- /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the appointment of John P. Hamill as Senior Vice President & Chief Financial Officer effective today. Mr. Hamill brings over 25 years of ... See all stories on this topic » | ||
| Ohr Pharmaceutical Initiates Phase II Trial of Squalamine Eye Drops For The ... Sacramento Bee NEW YORK, Sept. 24, 2012 -- /PRNewswire/ -- Ohr Pharmaceutical (OTCBB: OHRP-News) today announced the initiation of a Phase II clinical trial to evaluate the efficacy and safety of Squalamine Eye Drops for the treatment of the wet form of age-related ... See all stories on this topic » | ||
| McKesson Announces New President of US Pharmaceutical Business The Herald | HeraldOnline.com SAN FRANCISCO — McKesson Corporation (NYSE: MCK) today announced that Mark Walchirk has been named president, McKesson U.S. Pharmaceutical, effective immediately. Walchirk, who was most recently chief operating officer of McKesson Specialty ... See all stories on this topic » | ||
| Drug patents on the rise: 3488 in 5 years Business Standard Compare India's pharma patent number with that of Brazil, another BRIC (Brazil, Russia, India and China) nation, in a similar time band. A research paper, "Pharmaceutical Innovation, Incremental patenting and Compulsory Licensing" by Carlos M Correa, ... See all stories on this topic » | ||
| Top pharmaceutical companies form nonprofit body to speed drug development Business Recorder (blog) 0 Comments. E-mail · Print · PDF. Ten top pharmaceutical companies from the United States and Europe said they have formed a nonprofit organisation to accelerate the development of new drugs, a risky and expensive undertaking for companies of any size. See all stories on this topic » | ||
| Multi-Stage Pharmaceuticals With Investment Potential In The War On Cancer Seeking Alpha Listed in order of their various stages of development, the choices start with a biotech without even a clinical trial running yet, then goes onto a promising biotech in a large indication phase 3 trial, and culminates with a multi-billion dollar ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment